Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Harmony Biosciences
Harmony Biosciences
Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout
BioSpace
Tue, 08/15/23 - 11:36 am
Harmony Biosciences
Zynerba
M&A
neuropsychiatric
Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug
BioSpace
Thu, 03/30/23 - 10:03 am
Harmony Biosciences
Scorpion Capital
FDA
Wakix
narcolepsy
citizen petitions
Competition is on the horizon for costly narcolepsy treatments
Pharmaphorum
Wed, 12/14/22 - 10:26 am
narcolepsy
Jazz Pharmaceuticals
Molina Healthcare
Avadel
Harmony Biosciences
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Rare Diseases
Rare Disease Company Coalition
drug development
drug discovery
Acceleron
Aeglea BioTherapeutics
Agios Pharmaceuticals
Alnylam
Harmony Biosciences
Orchard Therapeutics
Orphazyme
Sarepta Therapeutics
Taysha Gene Therapies
Ultragenyx
Harmony’s sleep disorder drug Wakix gets US label extension
Pharmaforum
Wed, 10/14/20 - 05:45 pm
Harmony Biosciences
Wakix
nacrolepy
cataplexy
Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong
Endpoints
Thu, 08/20/20 - 10:50 am
Harmony Biosciences
Inhibrx
IPOs
Ex-biotech chief pleads guilty in college admissions scandal, faces a 10-month prison stretch in plea deal
Endpoints
Tue, 05/26/20 - 10:04 pm
Harmony Biosciences
scandal
Biohaven
Bob Repella
Harmony crosses finish line with Wakix for narcolepsy
BioCentury
Thu, 08/15/19 - 11:25 pm
Harmony Biosciences
Wakix
narcolepsy